PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of aacPermissionsJournals.ASM.orgJournalAAC ArticleJournal InfoAuthorsReviewers
 
Antimicrob Agents Chemother. 2017 April; 61(4): e01048-16.
Published online 2017 March 24. Prepublished online 2017 February 6. doi:  10.1128/AAC.01048-16
PMCID: PMC5365670

Multiclonal Expansion of Klebsiella pneumoniae Isolates Producing NDM-1 in Rio de Janeiro, Brazil

ABSTRACT

We characterized NDM-1-producing Klebsiella isolates from Rio de Janeiro, Brazil. PCR was applied for resistance and virulence determinants. The genetic context of blaNDM was determined by S1 nuclease pulsed-field gel electrophoresis (PFGE) and hybridization. Genotyping was performed by PFGE and multilocus sequence typing (MLST). Most isolates carried multiple resistance genes and remained susceptible to amikacin, fosfomycin-trometamol, polymyxin B, and tigecycline. The spread of NDM-1-producing Klebsiella pneumoniae was not associated with clonal expansion and appears to be associated with Tn3000.

KEYWORDS: Klebsiella pneumoniae, New Delhi metallo-β-lactamase, molecular typing, MLST, NDM carbapenemase

TEXT

New Delhi metallo-β-lactamase (NDM) is a clinically significant carbapenemase that is capable of inactivating almost all β-lactams (except aztreonam) (1, 2). Since the first description of NDM in 2009, in Klebsiella pneumoniae and Escherichia coli isolates from Sweden (1), NDM-producing bacteria have been reported worldwide (3).

The first description of NDM in Brazil was in Providencia rettgeri isolated from Rio Grande do Sul State (southern Brazil), in 2013 (4). Despite the chromosomal gene location, the hospital where that isolate was recovered began a retrospective and prospective search for NDM-producing bacteria, identifying Enterobacter hormaechei subsp. oharae isolates carrying the blaNDM-1 gene in plasmids (5). Active surveillance was subsequently initiated in the country, and there have been other reports involving NDM-producing Enterobacteriaceae, such as Enterobacter cloacae, Morganella morganii (6), E. coli, and K. pneumoniae (7). A draft genome of a NDM-1-producing K. pneumoniae (NPKP) isolate from Rio de Janeiro (GenBank accession no. JSER00000000) revealed several resistance genes for different antimicrobial classes (8). That isolate (CCBH13327) was included in this study for epidemiological analysis.

Here, we characterized 16 NDM-1-producing Klebsiella isolates from Rio de Janeiro State (southeast region of Brazil). The isolates were received by the Laboratório de Pesquisa em Infecção Hospitalar (Oswaldo Cruz Institute, Rio de Janeiro, Brazil). They were collected between July 2013 and November 2014 from eight health care institutions (H1 to H8) in three cities in the region (Rio de Janeiro, Niterói, and Campos dos Goytacazes) and were recovered from rectal swab (n = 7), urine (n = 3), blood (n = 4), catheter tip (n = 1), and cerebrospinal fluid (CSF) (n = 1) samples from nonconsecutive patients.

The isolates were identified as K. pneumoniae by conventional biochemical techniques, and the isolate CCBH16302 was identified as Klebsiella quasipneumoniae (9) by whole-genome sequencing. The MICs for meropenem, imipenem, tigecycline, and polymyxin B were determined by Etest (AB Biodisk, Sweden), and susceptibility to other antimicrobial agents was determined by agar diffusion. Phenotypic detection of carbapenemases was based on enzymatic blocking using EDTA and phenyl boronic acid (10) and in vitro analysis of imipenem hydrolysis by the Carba NP test (11).

Pulsed-field gel electrophoresis (PFGE) typing using the restriction enzyme XbaI and multilocus sequence typing (MLST) were performed for all isolates as indicated in the Pasteur Institute MLST databases (http://bigsdb.pasteur.fr/klebsiella/klebsiella.html). PCR assays were used to detect the β-lactamase-encoding genes blaNDM (12), blaKPC, blaOXA-48-like, blaIMP, blaVIM (13), blaCTX-M (14), blaSHV, blaTEM, and blaCMY (15) and the plasmid-mediated quinolone and aminoglycoside resistance determinants qnrA, qnrB, qnrS (16), aadA (17), aadB (18), aac(3′)-IIa (19), aac(6′)-Ib (20), rmtA, rmtB, rmtC, armA, npmA (21), and rmtD (22). The PCR products of blaNDM, blaKPC, and aac(6′)-Ib were subjected to DNA sequencing. The virulence factor-encoding genes cf29a, mrkD, fimH (23), entB, ycfM (24), iroN (25), kfu (26), magA (27), allS (28), and ybtS (29) were also searched by PCR. The hypermucoviscosity phenotype was detected by the string test (30).

Analysis of the genetic environment of the blaNDM gene was performed by PCR mapping, as described previously (12), and S1 nuclease PFGE, followed by Southern blot hybridization with a blaNDM probe. For further analysis, three representative isolates (CCBH13327, CCBH15949, and CCBH16302), belonging to different sequence types (STs), were subjected to whole-genome sequencing. The genomic DNA of the three strains was extracted with the QIAamp DNA Blood minikit (Qiagen, Germany) and was sequenced using an Illumina MiSeq platform (Illumina, USA). A genomic library was constructed by transposon tagmentation with the Nextera XT DNA sample preparation kit (Illumina). Sequence reads were then trimmed and filtered using a Phred score of >20. Geneious v.6.1.7 software (Biomatters, New Zealand) was used to perform de novo assembling. Genome annotation was performed with Rapid Annotation using Subsystem Technology (RAST) v.2.0 (http://rast.nmpdr.org).

The isolates were nonsusceptible to all β-lactams (100%) except for aztreonam (69%) and gentamicin, ciprofloxacin, and sulfamethoxazole-trimethoprim (75%) and remained susceptible to amikacin (81%) and fosfomycin-trometamol (94%), as determined according to CLSI guidelines (11). In accordance with EUCAST guidelines (31), the strains were considered susceptible to polymyxin B (87.5%) and tigecycline (69%) (Table 1). As reported previously, fosfomycin, polymyxin B, and tigecycline are the antimicrobials with the highest activities against NDM-1 producers (32).

TABLE 1
Resistance and virulence features of NDM-1-producing Klebsiella spp. from Rio de Janeiroa

All strains were phenotypically positive for metallo-β-lactamase production and harbored blaNDM-1. Other resistance genes (Table 1), including blaKPC-2, blaTEM, blaSHV, blaCTX-M, qnrA, qnrB, qnrS, aadA, aadB, aac(3)-IIa, aac(6′)-Ib, and its variants, were also found. The coproduction of blaNDM-1 with other β-lactamase genes and genetic determinants related to quinolone and aminoglycoside resistance was often detected (12). We also detected two strains (CCBH16059 and CCBH16505) carrying the blaNDM-1 and blaKPC-2 genes in separate plasmids; this finding has been described in E. hormaechei in Brazil (33), but this is the first description of K. pneumoniae coharboring blaNDM-1 and blaKPC-2 in this country. This finding is worrisome, since KPC-2-producing K. pneumoniae is already endemic in Brazil (34) and the spread of blaNDM-1 could be facilitated when associated with this successful pathogen.

The virulence genes observed included entB, fimH, yfcM, mrkD (100%), kfU (75%), and ybtS (25%). Four isolates were positive for the hypermucoviscosity phenotype (Table 1). However, no specific virulence factor has been associated with NDM-type producers. Apparently, the difficulty of treating infections caused by carbapenemase-producing Enterobacteriaceae is the most significant issue (32, 35).

PFGE and MLST analysis allowed us to identify nine pulsotypes (pulsotypes A to I) and nine STs (STs 37, 138, 323, 340, 365, 906, 1588, 1803, and 2279) (Fig. 1). The STs 37, 138, 323, and 365 were restricted to the same city and hospital (H1), and an outbreak of ST37 was identified among patients in the adult intensive care unit (ICU). ST1588 was identified in three hospitals in Rio de Janeiro city, and the common procedures for patient and staff transferences between hospitals could explain this finding. Although there are some reports of clonal spread (36, 37), our findings suggest that the spread of NPKP in Rio de Janeiro is not related to specific clones, as described commonly (32, 38). STs 138, 323, and 340 have been described in Brazil in association with KPC production (34); ST340 belongs to clonal complex 258 and was identified from a CSF sample. Furthermore, two new STs, i.e., ST1803 and ST2279, isolated from blood and rectal swab samples, respectively, were observed.

FIG 1
Dendrogram and epidemiological characteristics of NDM-1-producing Klebsiella spp. from Rio de Janeiro.

Plasmid analyses were successfully performed for 15/16 isolates. The plasmids carrying the blaNDM-1 gene had different sizes, ranging from ~87 to 430 kb (Table 1). The blaNDM-1 gene was associated with a truncated ISAba125 upstream and a bleMBL (bleomycin resistance) gene downstream in all isolates. For the three selected strains, namely, CCBH13327 (GenBank accession no. JSER00000000), CCBH15949 (GenBank accession no. MCGW00000000), and CCBH16302 (GenBank accession no. MDCA00000000), whole-genome sequencing showed that the blaNDM-1 gene was associated with the Tn3000 transposon (39). This structure was delimited by two copies of IS3000; the first copy truncated the 5′ portion of ISAba125 upstream of the blaNDM-1 gene, and bleMBL was present downstream, followed by trpF, tat, cutA1, groES, and groEL, truncated by the second copy of IS3000. The same genetic structure was reported previously for NDM-1-producing E. coli and E. hormaechei from Rio de Janeiro (39). Our findings support the suggestion that Tn3000 has a key role in the spread of the blaNDM-1 gene, since the gene was found in plasmids of different sizes even in genetically related strains.

The spread of NPKP in Rio de Janeiro involves nonclonal isolates harboring the blaNDM-1 gene in association with Tn3000 and a variety of determinants of resistance to different antimicrobial classes. To our knowledge, this is the first report of K. quasipneumoniae carrying blaNDM-1. We also highlight the possibility that some patients are serving as reservoirs for NDM-producing bacteria, because 44% of isolates were recovered from surveillance rectal swabs, which means that the detection of these isolates may be underestimated.

ACKNOWLEDGMENTS

This project was supported by the Conselho Nacional de Desenvolvimento Científico e Tecnológico, the Fundação Carlos Chagas de Amparo à Pesquisa, and the Instituto Oswaldo Cruz.

All authors report no conflicts of interest relevant to this article.

REFERENCES

1. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, Walsh TR 2009. Characterization of a new metallo-β-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 53:5046–5054. doi:.10.1128/AAC.00774-09 [PMC free article] [PubMed] [Cross Ref]
2. Nordmann P, Poirel L, Mark AT, Timothy RW 2011. Does broad-spectrum β-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria? J Antimicrob Chemother 66:689–692. doi:.10.1093/jac/dkq520 [PubMed] [Cross Ref]
3. Nordmann P, Poirel L 2014. The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. Clin Microbiol Infect 20:821–830. doi:.10.1111/1469-0691.12719 [PubMed] [Cross Ref]
4. Carvalho-Assef APD, Pereira PS, Albano RM, Berião GC, Chagas TPG, Timm LN, Da Silva RCF, Falci DR, Asensi MD 2013. Isolation of NDM-producing Providencia rettgeri in Brazil. J Antimicrob Chemother 68:2956–2957. doi:.10.1093/jac/dkt298 [PubMed] [Cross Ref]
5. Carvalho-Assef APD, Pereira PS, Albano RM, Berião GC, Tavares CP, Chagas TPG, Marques EA, Timm LN, Da Silva RCF, Falci DR, Asensi MD 2014. Detection of NDM-1-, CTX-M-15-, and qnrB4-producing Enterobacter hormaechei isolates in Brazil. Antimicrob Agents Chemother 58:2475–2476. doi:.10.1128/AAC.02804-13 [PMC free article] [PubMed] [Cross Ref]
6. Rozales FP, Ribeiro VB, Magagnin CM, Pagano M, Lutz L, Falci DR, Machado A, Barth AL, Zavascki AP 2014. Emergence of NDM-1-producing Enterobacteriaceae in Porto Alegre, Brazil. Int J Infect Dis 25:79–81. doi:.10.1016/j.ijid.2014.01.005 [PubMed] [Cross Ref]
7. Carneiro M, Gonçalves RA, de Souza JG, Teixeira CB, Krummenauer EC, Machado JAA, Waib LF, Pina Trench FJ 2014. New carbapenases in Brazil. Expert Rev Anti Infect Ther 12:155–156. doi:.10.1586/14787210.2014.867804 [PubMed] [Cross Ref]
8. Pereira PS, Albano RM, Asensi MD, Carvalho-Assef APD 2015. Draft genome sequences of three NDM-1-producing Enterobacteriaceae species isolated from Brazil. Mem Inst Oswaldo Cruz 110:580–582. [PMC free article] [PubMed]
9. Brisse S, Passet V, Grimont PA 2014. Description of Klebsiella quasipneumoniae sp. nov., isolated from human infections, with two subspecies, Klebsiella quasipneumoniae subsp. quasipneumoniae subsp. nov. and Klebsiella quasipneumoniae subsp. similipneumoniae subsp. nov., and demonstration that Klebsiella singaporensis is a junior heterotypic synonym of Klebsiella variicola. Int J Syst Evol Microbiol 64:3146–3152. doi:.10.1099/ijs.0.062737-0 [PubMed] [Cross Ref]
10. Agência Nacional de Vigilância Sanitária (ANVISA). 2013. Medidas de prevenção e controle de infecções por enterobactérias multiresistentes. Nota Técnica 01/2013 ANVISA; Brasília, Brazil.
11. Clinical and Laboratory Standards Institute. 2015. Performance standards for antimicrobial susceptibility testing; 25th informational supplement. Document M100-S25. Clinical and Laboratory Standards Institute, Wayne, PA.
12. Poirel L, Dortet L, Bernabeu S, Nordmann P 2011. Genetic features of blaNDM-1-positive Enterobacteriaceae. Antimicrob Agents Chemother 55:5403–5407. doi:.10.1128/AAC.00585-11 [PMC free article] [PubMed] [Cross Ref]
13. Monteiro J, Widen RH, Pignatari ACC, Kubasek C, Silbert S 2012. Rapid detection of carbapenemase genes by multiplex real-time PCR. J Antimicrob Chemother 67:906–909. doi:.10.1093/jac/dkr563 [PubMed] [Cross Ref]
14. Mulvey MR, Soule G, Boyd D, Demczuk W, Ahmed R 2003. Characterization of the first extended-spectrum β-lactamase-producing Salmonella isolate identified in Canada. J Clin Microbiol 41:460–462. doi:.10.1128/JCM.41.1.460-462.2003 [PMC free article] [PubMed] [Cross Ref]
15. Hasman H, Mevius D, Veldman K, Olesen I, Aarestrup FM 2005. β-Lactamases among extended-spectrum β-lactamase (ESBL)-resistant Salmonella from poultry, poultry products and human patients in the Netherlands. J Antimicrob Chemother 56:115–121. doi:.10.1093/jac/dki190 [PubMed] [Cross Ref]
16. Cattoir V, Poirel L, Rotimi V, Soussy CJ, Nordmann P 2007. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother 60:394–397. doi:.10.1093/jac/dkm204 [PubMed] [Cross Ref]
17. Enne VI, Delsol AA, Roe JM, Bennett PM 2006. Evidence of antibiotic resistance gene silencing in Escherichia coli. Antimicrob Agents Chemother 50:3003–3010. doi:.10.1128/AAC.00137-06 [PMC free article] [PubMed] [Cross Ref]
18. Díaz P, Bello H, Domínguez M, Trabal N, Mella S, Zemelman R, González G 2004. Resistance to gentamicin, amikacin and ciprofloxacin among nosocomial isolates of Klebsiella pneumoniae subspecie pneumoniae producing extended spectrum β-lactamases. Rev Med Chile 132:1173–1178. (In Spanish.) [PubMed]
19. Melano R, Corso A, Petroni A, Centrón D, Orman B, Pereyra A, Moreno N, Galas M 2003. Multiple antibiotic-resistance mechanisms including a novel combination of extended-spectrum β-lactamases in a Klebsiella pneumoniae clinical strain isolated in Argentina. J Antimicrob Chemother 52:36–42. doi:.10.1093/jac/dkg281 [PubMed] [Cross Ref]
20. Warburg G, Hidalgo-Grass C, Partridge SR, Tolmasky ME, Temper V, Moses AE, Block C, Strahilevitz J 2012. A carbapenem-resistant Klebsiella pneumoniae epidemic clone in Jerusalem: sequence type 512 carrying a plasmid encoding aac(6′)-Ib. J Antimicrob Chemother 67:898–901. doi:.10.1093/jac/dkr552 [PubMed] [Cross Ref]
21. Fritsche TR, Castanheira M, Miller GH, Jones RN, Armstrong ES 2008. Detection of methyltransferases conferring high-level resistance to aminoglycosides in enterobacteriaceae from Europe, North America, and Latin America. Antimicrob Agents Chemother 52:1843–1845. doi:.10.1128/AAC.01477-07 [PMC free article] [PubMed] [Cross Ref]
22. Castanheira M, Fritsche TR, Sader HS, Jones RN 2008. RmtD 16S RNA methylase in epidemiologically unrelated SPM-1-producing Pseudomonas aeruginosa isolates from Brazil. Antimicrob Agents Chemother 52:1587–1588. doi:.10.1128/AAC.01502-07 [PMC free article] [PubMed] [Cross Ref]
23. Brisse S, Fevre C, Passet V, Issenhuth-Jeanjean S, Tournebize R, Diancourt L, Grimont P 2009. Virulent clones of Klebsiella pneumoniae: identification and evolutionary scenario based on genomic and phenotypic characterization. PLoS One 4(3):e4982. doi:.10.1371/journal.pone.0004982 [PMC free article] [PubMed] [Cross Ref]
24. Lafeuille E, Decré D, Mahjoub-Messai F, Bidet P, Arlet G, Bingen E 2013. OXA-48 carbapenemase-producing Klebsiella pneumoniae isolated from Libyan patients. Microb Drug Resist 19:491–497. doi:.10.1089/mdr.2012.0219 [PubMed] [Cross Ref]
25. Yu WL, Ko WC, Cheng KC, Lee CC, Lai CC, Chuang YC 2008. Comparison of prevalence of virulence factors for Klebsiella pneumoniae liver abscesses between isolates with capsular K1/K2 and non-K1/K2 serotypes. Diagn Microbiol Infect Dis 62:1–6. doi:.10.1016/j.diagmicrobio.2008.04.007 [PubMed] [Cross Ref]
26. Ma L-C, Fang C-T, Lee C-Z, Shun C-T, Wang J-T 2005. Genomic heterogeneity in Klebsiella pneumoniae strains is associated with primary pyogenic liver abscess and metastatic infection. J Infect Dis 192:117–128. doi:.10.1086/430619 [PubMed] [Cross Ref]
27. Fang C-T, Chuang Y-P, Shun C-T, Chang S-C, Wang J-T 2004. A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications. J Exp Med 199:697–705. doi:.10.1084/jem.20030857 [PMC free article] [PubMed] [Cross Ref]
28. Chou H, Lee C, Ma L, Fang C, Chang S, Wang J 2004. Isolation of a chromosomal region of Klebsiella pneumoniae associated with allantoin metabolism and liver infection. Infect Immun 72:3783–3792. [PMC free article] [PubMed]
29. Bachman MA, Oyler JE, Burns SH, Caza M, Lépine F, Dozois CM, Weiser JN 2011. Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2. Infect Immun 79:3309–3316. doi:.10.1128/IAI.05114-11 [PMC free article] [PubMed] [Cross Ref]
30. Shon AS, Bajwa RP, Russo TA 2013. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence 4:107–118. doi:.10.4161/viru.22718 [PMC free article] [PubMed] [Cross Ref]
31. European Committee on Antimicrobial Susceptibility Testing. 2015. Breakpoint tables for interpretation of MICs and zone diameters, version 5.0. European Committee on Antimicrobial Susceptibility Testing, Växjö, Sweden: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_5.0_Breakpoint_Table_01.pdf.
32. Nordmann P, Naas T, Poirel L 2011. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 17:1791–1798. doi:.10.3201/eid1710.110655 [PMC free article] [PubMed] [Cross Ref]
33. Pereira PS, Borghi M, Albano RM, Lopes JCO, Silveira MC, Marques EA, Oliveira JCR, Asensi MD, Carvalho-Assef APD 2015. Coproduction of NDM-1 and KPC-2 in Enterobacter hormaechei from Brazil. Microb Drug Resist 21:234–236. doi:.10.1089/mdr.2014.0171 [PubMed] [Cross Ref]
34. Pereira PS, de Araujo CFM, Seki LM, Zahner V, Carvalho-Assef APD, Asensi MD 2013. Update of the molecular epidemiology of KPC-2-producing Klebsiella pneumoniae in Brazil: spread of clonal complex 11 (ST11, ST437 and ST340). J Antimicrob Chemother 68:312–316. doi:.10.1093/jac/dks396 [PubMed] [Cross Ref]
35. Pitout JDD, Nordmann P, Poirel L 2015. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother 59:5873–5884. doi:.10.1128/AAC.01019-15 [PMC free article] [PubMed] [Cross Ref]
36. Jin Y, Shao C, Li J, Fan H, Bai Y, Wang Y 2015. Outbreak of multidrug resistant NDM-1-producing Klebsiella pneumoniae from a neonatal unit in Shandong Province, China. PLoS One 10:e0119571. doi:.10.1371/journal.pone.0119571 [PMC free article] [PubMed] [Cross Ref]
37. Baraniak A, Izdebski R, Fiett J, Gawryszewska I, Bojarska K, Herda M, Literacka E, Żabicka D, Tomczak H, Pewińska N, Szarata M, Ozorowski T, Milner A, Hryniewicz W, Gniadkowski M 2016. NDM-producing Enterobacteriaceae in Poland, 2012–14: inter-regional outbreak of Klebsiella pneumoniae ST11 and sporadic cases. J Antimicrob Chemother 71:85–91. doi:.10.1093/jac/dkv282 [PubMed] [Cross Ref]
38. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, Chaudhary U, Doumith M, Giske CG, Irfan S, Krishnan P, Kumar AV, Maharjan S, Mushtaq S, Noorie T, Paterson DL, Pearson A, Perry C, Pike R, Rao B, Ray U, Sarma JB, Sharma M, Sheridan E, Thirunarayan MA, Turton J, Upadhyay S, Warner M, Welfare W, Livermore DM, Woodford N 2010. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10:597–602. doi:.10.1016/S1473-3099(10)70143-2 [PMC free article] [PubMed] [Cross Ref]
39. Campos JC, da Silva MJF, dos Santos PRN, Barros EM, Pereira MDO, Seco BMS, Magagnin CM, Leiroz LK, de Oliveira TGM, de Faria C, Cerdeira LT, Barth AL, Sampaio SCF, Zavascki AP, Poirel L, Sampaio JLM 2015. Characterization of Tn3000, a transposon responsible for blaNDM-1 dissemination among Enterobacteriaceae in Brazil, Nepal, Morocco and India. Antimicrob Agents Chemother 59:7387–7395. doi:.10.1128/AAC.01458-15 [PMC free article] [PubMed] [Cross Ref]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)